|1.||Mignot, Emmanuel: 12 articles (05/2011 - 10/2002)|
|2.||Plazzi, Giuseppe: 6 articles (06/2015 - 11/2005)|
|3.||Longstreth, W T: 5 articles (03/2012 - 01/2009)|
|4.||Ton, Thanh G N: 5 articles (03/2012 - 01/2009)|
|5.||Lin, Ling: 5 articles (05/2011 - 06/2006)|
|6.||Bittencourt, Lia Rita Azeredo: 5 articles (10/2010 - 06/2007)|
|7.||Pradella-Hallinan, Márcia: 5 articles (10/2010 - 06/2007)|
|8.||Dauvilliers, Yves: 5 articles (03/2010 - 02/2002)|
|9.||Krahn, Lois E: 5 articles (09/2005 - 03/2002)|
|10.||Coelho, Fernando Morgadinho Santos: 4 articles (10/2010 - 06/2007)|
11/01/2002 - "No antibody test yielded significantly positive results for the group as a whole or for subgroups of patients with cataplexy or positive HLA DQB1*0602 status. "
12/15/2004 - "The objectives of the present study were to determine whether the month-of-birth pattern would (a) vary with the presence and severity of cataplexy and (b) differ for patients positive and negative for HLA-DQB1*0602. "
04/01/2008 - "Among three narcoleptics with cataplexy, two subjects were HLA-DQB1*0602 and DRB1*1501 positive, but one subject had no test of HLA typing. "
06/01/2007 - "The HLA-DQB1*0602 allele was identified in 10 (62.5%) of our 16 cataplexic subjects and in 2 (33.3%) of the 6 patients without cataplexy (p=0.24). "
02/01/2007 - "In cataplexy-positive patients, as compared with cataplexy-negative patients, the frequency of HLA-DQB1*0602 was found to be significantly high (89.3% vs. 50.0%) (p=0.003). "
10/01/2015 - "They were ultimately diagnosed with coexisting narcolepsy, confirmed by sleep studies and multiple sleep latency testing, along with positive genetic testing for HLA-DQB1*0602 in all three patients. "
03/01/2012 - "We investigated the association between birth order and narcolepsy risk in a population-based case-control study in which all study subjects were HLA-DQB1*0602 positive. "
03/18/2014 - "HLA-DQB1* 0602 is an important marker in this large sample of Chinese patients with narcolepsy.Its"
03/18/2014 - "Among those with hcrt-1 measurement, 98.3% (113/115) were HLA-DQB1*0602 positive in hcrt deficiency narcolepsy group versus 25.6% (11/43) in hcrt non-deficiency group (χ² = 94.6, P = 0.001). "
04/02/2013 - "Pandemrix vaccination is a precipitating factor for narcolepsy, especially in combination with HLA-DQB1*0602. "
|3.||Schizophrenia (Dementia Praecox)
01/17/1997 - "The authors attempted a replication of an earlier study of African-Americans, in which they detected a negative association of schizophrenia with HLA DQB1*0602. "
01/17/1997 - "Patients with schizophrenia (n = 75, DSM-III-R criteria) and screened adult controls of African-American ethnicity (n = 66) were genotyped with respect to HLA DQB1*0602 using a combination of two polymerase chain reaction (PCR) based assays: amplification with sequence specific primers and a dot blot assay. "
01/17/1997 - "Negative association of schizophrenia with HLA DQB1*0602: evidence from a second African-American cohort."
12/01/1996 - "The HLA DQB1*0602 allele was also studied because of previous reports of genetic association between it and schizophrenia. "
01/01/1993 - "A significant negative association of allele HLA DQB1*0602 with schizophrenia was present among African-Americans (odds ratio 0.19), but could not be detected in Caucasians."
03/01/2009 - "The present study describes the prevalence of HLA-DQB1*0602 allele in narcoleptics with and without cataplexy and in patients with idiopathic hypersomnia. "
03/01/2009 - "The prevalence of the HLA-DQB1*0602 allele was increased in idiopathic hypersomnia and in narcoleptic patients with and without cataplexy when compared to healthy subjects (p = 0.04; p = 0.03 and p < 0.0001, respectively). "
03/01/2009 - "Narcolepsy (with and without cataplexy) and idiopathic hypersomnia, are disorders with common features but with different HLA-DQB1*0602 allele prevalence. "
03/01/2009 - "Prevalence of the HLA-DQB1*0602 allele in narcolepsy and idiopathic hypersomnia patients seen at a sleep disorders outpatient unit in São Paulo."
01/01/2010 - "The distribution of serum IgG was significantly different among healthy controls negative for the HLA-DQB1*0602 allele (11.66+/-3.55 mg/ml), healthy controls positive for the HLA-DQB1*0602 allele (11.45+/-3.43), narcolepsy patients (9.67+/-3.38), and idiopathic hypersomnia patients (13.81+/-3.80). "
|5.||Disorders of Excessive Somnolence (Hypersomnia)
10/01/2002 - "HLA-DQB1*0602 frequency was increased in narcolepsy with typical cataplexy (93% vs 17% in controls), narcolepsy without cataplexy (56%), and in essential hypersomnia (52%). "
05/01/2011 - "A total of 417 children (< 18 years old) successively presenting with complaints of hypersomnia without anatomic cause or sleep apnea risk were evaluated using the Stanford Sleep Inventory, human leukocyte antigen (HLA) DQB1*0602 typing, and MSLT recordings. "
01/01/2003 - "This study reports the findings of a prospective study measuring cerebrospinal fluid concentrations of hypocretin-1 and hypocretin-2 in HLA DQB1*0602 positive narcolepsy with cataplexy, monosymptomatic narcolepsy, and primary hypersomnia. "
10/01/2002 - "There were 274 patients with narcolepsy; hypersomnia; obstructive sleep apnea; restless legs syndrome; insomnia; and atypical hypersomnia cases such as familial cases, narcolepsy without cataplexy or without HLA-DQB1*0602, recurrent hypersomnias, and symptomatic cases (eg, Parkinson disease, depression, Prader-Willi syndrome, Niemann-Pick disease type C). "
|2.||HLA-DQB1 antigen (HLA DQB1)
|4.||HLA-DRB1 antigen (HLA DRB1)
|5.||Interleukin-12 (IL 12)
|6.||Macrophage Colony-Stimulating Factor
|7.||Interleukin-6 (Interleukin 6)
|8.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|10.||HLA DQB1 0201 antigen